March 31 (Reuters) - The U.S. Federal Trade Commission said it filed a complaint in a district court accusing some drugmakers, including Endo International Plc, of violating antitrust laws by striking deals to block consumers' access to generic copies of their drugs.
Read more
No comments:
Post a Comment